Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
2,673,800
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
508,154
-
Shares change
-
-10,359
-
Total reported value, excl. options
-
$297,499
-
Value change
-
-$7,049
-
Number of buys
-
8
-
Number of sells
-
-2
-
Price
-
$0.5850
Significant Holders of Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) as of Q2 2025
11 filings reported holding DRMA - Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q2 2025.
Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 508,154 shares
of 2,673,800 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (322,179 shares), UBS Group AG (90,955 shares), XTX Topco Ltd (34,492 shares), GEODE CAPITAL MANAGEMENT, LLC (27,385 shares), TWO SIGMA SECURITIES, LLC (14,724 shares), JONES FINANCIAL COMPANIES LLLP (12,000 shares), Tower Research Capital LLC (TRC) (5,318 shares), SBI Securities Co., Ltd. (1,010 shares), CITIGROUP INC (60 shares), and BANK OF AMERICA CORP /DE/ (31 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.